Respiratory Syncytial Virus (RSV) Diagnostics Market Report by Product (Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test (RADTs), Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, and Others), End Use (Hospitals and Clinics, Laboratory, and Others), and Region 2025-2033
Market Report I 2025-09-01 I 144 Pages I IMARC Group
The global respiratory syncytial virus (RSV) diagnostics market size reached USD 1,087.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,152.0 Million by 2033, exhibiting a growth rate (CAGR) of 7.9% during 2025-2033.
Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which can cause asthma, hospitalization, pneumonia, repeated infections, middle ear infection, and death. It can be diagnosed using blood tests, chest x-rays, a swab of secretions, and pulse oximetry by checking for signs like lung inflammation, white blood cell (WBC) count, and oxygen levels in the blood. Some of the commonly available treatment options for RSV are over-the-counter (OTC) medications, intravenous (IV) fluids, humidified oxygen, mechanical ventilation, and inhaled bronchodilators.
Respiratory Syncytial Virus (RSV) Diagnostics Market Trends:
RSV infection can be more serious during the neonatal period as children under two years of age tend to develop severe respiratory symptoms. This, in confluence with the rising focus of parents on child medical care, represents one of the crucial factors fostering the growth of the market. Moreover, the high survival rates after early diagnosis and the easy availability of diagnostic modalities act as other growth-inducing factors. Apart from this, the improving healthcare infrastructure and favorable reimbursement policies for the treatment of hospitalized infants are also contributing to market growth. Furthermore, the advent of advanced techniques like bio- and nanotechnology is facilitating the development of modern detection systems for RSV, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). Besides this, governing agencies of numerous countries are funding research and development (R&D) projects for the development of new therapeutics. Other factors projected to drive the market are the growing number of clinical vaccine trials, the escalating demand for in-vitro diagnostics, rising incidences of childhood pneumonia and the increasing adoption of molecular diagnostics.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory syncytial virus (RSV) diagnostics market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product and end use.
Breakup by Product:
- Direct Fluorescent Antibody (DFA) Method
- Rapid Antigen Diagnostic Test (RADTs)
- Molecular Diagnostics
- Chromatographic Immunoassay
- Diagnostic Imaging
- Gel Microdroplets
- Flow Cytometry
- Others
Breakup by End Use:
- Hospitals and Clinics
- Laboratory
- Others
Breakup by Region:
- North America
o United States
o Canada
- Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
- Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
- Latin America
o Brazil
o Mexico
o Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global respiratory syncytial virus (RSV) diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global respiratory syncytial virus (RSV) diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global respiratory syncytial virus (RSV) diagnostics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Direct Fluorescent Antibody (DFA) Method
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Rapid Antigen Diagnostic Test (RADTs)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Molecular Diagnostics
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Chromatographic Immunoassay
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Diagnostic Imaging
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Gel Microdroplets
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Flow Cytometry
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by End Use
7.1 Hospitals and Clinics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Laboratory
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Becton, Dickinson and Company
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 bioMerieux SA
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bio-Rad Laboratories Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Coris BioConcept
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 DiaSorin Molecular LLC (DiaSorin Inc)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 F. Hoffmann-La Roche AG
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 SWOT Analysis
13.3.8 Merck KGaA
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Quest Diagnostics Incorporated
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Quidel Corporation
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Thermo Fisher Scientific Inc.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
Figure 1: Global: Respiratory Syncytial Virus Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Product (in %), 2024
Figure 5: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by End Use (in %), 2024
Figure 6: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Region (in %), 2024
Figure 7: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: North America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: North America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: United States: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: United States: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Canada: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Canada: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: China: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: China: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Japan: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Japan: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: India: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: India: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: South Korea: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: South Korea: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Australia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Australia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Indonesia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Indonesia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Europe: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Europe: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Germany: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Germany: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: France: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: France: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: United Kingdom: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: United Kingdom: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Italy: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Italy: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Spain: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Spain: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Russia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Russia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Latin America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Latin America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Brazil: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Brazil: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Mexico: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Mexico: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Breakup by Country (in %), 2024
Figure 77: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Global: Respiratory Syncytial Virus Diagnostics Industry: SWOT Analysis
Figure 79: Global: Respiratory Syncytial Virus Diagnostics Industry: Value Chain Analysis
Figure 80: Global: Respiratory Syncytial Virus Diagnostics Industry: Porter's Five Forces Analysis
Table 1: Global: Respiratory Syncytial Virus Diagnostics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by End Use (in Million USD), 2025-2033
Table 4: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Respiratory Syncytial Virus Diagnostics Market: Competitive Structure
Table 6: Global: Respiratory Syncytial Virus Diagnostics Market: Key Players
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.